Literature DB >> 11355404

Death after excessive propofol abuse.

S Iwersen-Bergmann1, P Rösner, H C Kühnau, M Junge, A Schmoldt.   

Abstract

Abuse of the anaesthetic agent propofol (2,6-diisopropylphenol) is rare, but we report a case of a 26-year-old male nurse in which the autopsy showed unspecific signs of intoxication and criminological evidence pointed towards propofol abuse and/or overdose. Intravenously administered propofol is a fast and short-acting narcotic agent, therefore it seemed questionable whether the deceased would have been able to self-administer a lethal overdose before losing consciousness. The blood and brain concentrations corresponded to those found 1-2 min after bolus administration of a narcotic standard dose of 2.5 mg propofol/kg body weight. Extremely high propofol concentrations were found in the urine indicating excessive abuse before death. However, due to the short half-life of propofol, the cumulative effects of repeated injections should not be relevant for toxicity, since this would result in a blood level increase of only 1-2 micrograms/ml. Furthermore, the detection and quantitation of propofol in three different hair segments indicated chronic propofol abuse by the deceased. The results of the investigation suggest that death was not caused by a propofol overdose but by respiratory depression resulting from overly rapid injection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355404     DOI: 10.1007/s004149900129

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  9 in total

1.  [Life-threatening fentanyl and propofol addiction: interview with a survivor].

Authors:  C Maier; J Leclerc-Springer
Journal:  Anaesthesist       Date:  2012-07       Impact factor: 1.041

Review 2.  Clinical effects and lethal and forensic aspects of propofol.

Authors:  Richard J Levy
Journal:  J Forensic Sci       Date:  2010-10-15       Impact factor: 1.832

3.  Circumstantial and toxicological features of deaths from self-administered intravenous anesthetic/narcotic agents.

Authors:  Takahito Hayashi; Claas Buschmann; Benno Riesselmann; Sonja Roscher; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2012-08-28       Impact factor: 2.007

4.  Dependence potential of propofol: behavioral pharmacology in rodents.

Authors:  Hye Jin Cha; Ji-Hun Cha; Hea-Young Cho; Eun-Yong Chung; Kyoung-Jin Kwon; Jun Yeon Lee; Ho-Sang Jeong; Hye-Soo Kim; Hye-Joo Chung; Eun Jung Kim
Journal:  Biomol Ther (Seoul)       Date:  2012-03       Impact factor: 4.634

5.  Severity and duration of mental deficiency symptoms after intravenous administration of propofol.

Authors:  S Seidl; R Hausmann; J Neisser; H-D Janisch; P Betz
Journal:  Int J Legal Med       Date:  2006-07-05       Impact factor: 2.791

6.  Conscious sedation using propofol versus midazolam in cirrhotic patients during upper GI endoscopy: A comparative study.

Authors:  Essam A Wahab; Emad F Hamed; Hanan S Ahmad; Sameh M Abdel Monem; Talaat Fathy
Journal:  JGH Open       Date:  2018-10-23

7.  Clinical and psychological characteristics of propofol abusers in Korea: a survey of propofol abuse in 38, non-healthcare professionals.

Authors:  Eun-Jung Kim; Seon-Hwa Kim; Yang-Jin Hyun; Yeon-Keun Noh; Ho-Sang Jung; Soon-Young Han; Chan-Hye Park; Byung Moon Choi; Gyu-Jeong Noh
Journal:  Korean J Anesthesiol       Date:  2015-11-25

8.  Is propofol safe when administered to cirrhotic patients during sedative endoscopy?

Authors:  Sang Jun Suh; Hyung Joon Yim; Eileen L Yoon; Beom Jae Lee; Jong Jin Hyun; Sung Woo Jung; Ja Seol Koo; Ji Hoon Kim; Kyung Jin Kim; Rok Son Choung; Yeon Seok Seo; Jong Eun Yeon; Soon Ho Um; Kwan Soo Byun; Sang Woo Lee; Jai Hyun Choi; Ho Sang Ryu
Journal:  Korean J Intern Med       Date:  2014-01-02       Impact factor: 2.884

Review 9.  Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.